
Morning Immunotherapy Effect in Question as Key Study Is Retracted
Nature Medicine retracted a Chinese trial that claimed morning administration of immunotherapy yielded dramatic cancer benefits, citing concerns about data integrity; the ruling undermines the reported timing advantage and leaves clinicians cautious about changing practice.













